Billable / Specific Code
ICD-10-CM C7A.095 is the diagnosis code for Malignant carcinoid tumor of the midgut, unspecified. This code falls under the section "Malignant neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where C7A.095 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C7A.095 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C7A.095 is the ICD-10-CM diagnosis code for "Malignant carcinoid tumor of the midgut, unspecified". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C7A.095 is C7A.09 ("Malignant carcinoid tumors of other sites"). C7A.095 provides a more specific classification within this category.
C7A.095 is located in Section C7A — "Malignant neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
Use C7A.095 when the patients documented diagnosis matches "Malignant carcinoid tumor of the midgut, unspecified" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant carcinoid tumor of the midgut, unspecified is C7A.095.
Yes, C7A.095 can be used as a primary diagnosis code since it is billable and specific.
C7A.095 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C7A.095 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.